ENTA Past Earnings image   This ENTA past earnings page last updated 11/23/2022
ENTA Past Earnings
PeriodPast Earnings DateGAAP
Q4 202211/21/2022-1.270
Q3 20228/8/2022-1.530
Q2 20225/9/2022-1.630
Q1 20222/8/2022-1.480
Q4 202111/22/2021-1.220
Q3 20218/5/2021-1.190
Q2 20215/6/2021-1.090
Q1 20212/8/2021-0.410
Q4 202011/23/2020-1.460
Q3 20208/4/2020-0.710
Q2 20205/6/2020-0.300
Q1 20202/6/20200.650
Q4 201911/21/20190.440
Q3 20198/6/20190.330
Q2 20195/7/20190.200
Q1 20192/6/20191.25
Q4 201811/26/20181.3
Q3 20188/7/20180.97
Q2 20185/8/20180.61
Q1 20182/7/20180.78
Q4 201711/20/20171.86
Q3 20178/7/2017-0.44
Q2 20175/8/2017-0.28
Q1 20172/8/2017-0.26
Q4 201611/21/2016-0.09
Q3 20168/8/2016-0.06
Q2 20165/9/2016-0.09
Q1 20162/8/20161.36
Q4 201511/23/20150.29
Q3 20158/6/20150.13
Q2 20155/7/20151.49
Q1 20152/5/20152.18
Q4 201411/24/2014-0.27
Q3 20148/11/20142.61
Q2 20145/12/2014-0.28
Q1 20142/13/2014-0.3
Q4 201311/25/2013-0.250
Q3 20138/12/2013-0.23
Q2 20135/8/2013-2.28
ENTA Past Revenue
PeriodPast Earnings DateGAAP
Q4 202211/21/20220.02B
Q3 20228/8/20220.02B
Q2 20225/9/20220.02B
Q1 20222/8/20220.03B
Q4 202111/22/20210.02B
Q3 20218/5/20210.02B
Q2 20215/6/20210.02B
Q1 20212/8/20210.03B
Q4 202011/23/20200.02B
Q3 20208/4/20200.02B
Q2 20205/6/20200.03B
Q1 20202/6/20200.05B
Q4 201911/21/20190.05B
Q3 20198/6/20190.04B
Q2 20195/7/20190.04B
Q1 20192/6/201969.89M
Q4 201811/26/201867.20M
Q3 20188/7/201857.26M
Q2 20185/8/201844.05M
Q1 20182/7/201838.11M
Q4 201711/20/201775.93M
Q3 20178/7/20177.51M
Q2 20175/8/20178.96M
Q1 20172/8/201710.42M
Q4 201611/21/201612.84M
Q3 20168/8/201613.98M
Q2 20165/9/201613.00M
Q1 20162/8/201648.45M
Q4 201511/23/201514.42M
Q3 20158/6/201511.60M
Q2 20155/7/201557.37M
Q1 20152/5/201577.50M
Q4 201411/24/20142.60M
Q3 20148/11/201442.10M
Q2 20145/12/20142.16M
Q1 20142/13/2014893000
Q4 201311/25/20130.00B
Q3 20138/12/20131.65M
Q2 20135/8/20131.20M
Quotes delayed 20 minutes

Email EnvelopeFree ENTA Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Enanta Pharmaceuticals (ENTA) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

ENVB Past Earnings
ENZ Past Earnings
EOLS Past Earnings
EPZM Past Earnings
EQ Past Earnings
ERAS Past Earnings
ESPR Past Earnings
ETNB Past Earnings
ETON Past Earnings
ETTX Past Earnings

ENTA Past Earnings Q&A

What was the best and worst ENTA past earnings results?
For Enanta Pharmaceuticals, I'm wondering what the company's very best and worst earnings results have been, on an earnings per share basis?

✔️Accepted answer: The highest ENTA past earnings result in our data set was 2.61/share posted in Q3 2014, while the lowest was in Q2 2013 when ENTA posted -2.28/share.

  Suggested answer: The biggest top line earnings performance — aka revenue — quarter was in Q1 2015 when ENTA reported 77.50M in revenue, while the quarter with the lowest revenue in our data set was Q1 2014 at 893000 of revenue.

  Suggested answer: There are 39 ENTA past earnings results in our data set.

On this page we presented the ENTA past earnings date information for Enanta Pharmaceuticals. Reviewing that ENTA Past Earnings for the company, we see that the highest past earnings result in our data set was in Q3 2014, when ENTA posted gaap of 2.61/share. Meanwhile the lowest ENTA past earnings result was in Q2 2013, when ENTA posted gaap of -2.28/share. Turning to top line revenue performance, the biggest revenue quarter in our data set was seen in Q1 2015 when ENTA reported 77.50M in revenue, while the smallest revenue quarter was Q1 2014 when ENTA reported 893000 in revenue.

Any self directed investor doing their due diligence on ENTA or any other given stock can benefit from researching all of the Enanta Pharmaceuticals past earnings — and here, we present each quarter's result all together on one page for easy comparison. Studying this information can help when projecting future earnings, as well as determining whether the past earnings trajectory justifies the current stock value. That's why we bring you PastEarnings.com to make it easy for investors to investigate Enanta Pharmaceuticals past earnings, or the past earnings information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for ENTA. Thanks for visiting, and the next time you need to research ENTA past earnings or those of another stock, we hope you'll think of our site, as your go-to past earnings research resource of choice.

Recommended: SCC shares outstanding history, Funds Holding Philip Morris International, FUSB Historical Stock Prices.

 

ENTA Past Earnings | www.PastEarnings.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in PastEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.